Abstract:Atherosclerosis is a chronic, multifactorial inflammatory disorder of large and medium-size arteries, which is the leading cause of cardiovascular mortality and morbidity worldwide. Although platelets in cardiovascular disease have mainly been studied for their crucial role in the thrombotic event triggered by atherosclerotic plaque rupture, over the last two decades it has become clear that platelets participate also in the development of atherosclerosis, owing to their ability to interact with the damaged arterial wall and with leukocytes. Platelets participate in all phases of atherogenesis, from the initial functional damage to endothelial cells to plaque unstabilization. Platelets deposit at atherosclerosis predilection sites before the appearance of manifest lesions to the endothelium and contribute to induce endothelial dysfunction, thus supporting leukocyte adhesion to the vessel wall. In particular, platelets release matrix metalloproteinases, which interact with protease-activated receptor 1 on endothelial cells triggering adhesion molecule expression. Moreover, P-selectin and glycoprotein Ibα expressed on the surface of vessel wall-adhering platelets bind PSGL-1 and β2 integrins on leukocytes, favoring their arrest and transendothelial migration. Platelet–leukocyte interactions promote the formation of radical oxygen species which are strongly involved in the lipid peroxidation associated with atherosclerosis. Platelets themselves actively migrate through the endothelium toward the plaque core where they release chemokines that modify the microenvironment by modulating the function of other inflammatory cells, such as macrophages. While current antiplatelet agents seem unable to prevent the contribution of platelets to atherogenesis, the inhibition of platelet secretion, of the release of MMPs, and of some specific pathways of platelet adhesion to the vessel wall may represent promising future strategies for the prevention of atheroprogression. Article published online: 19 November 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

Platelets, inflammation and atherosclerosis

Thrombosis formation on atherosclerotic lesions and plaque rupture

Platelets, a Key Cell in Inflammation and Atherosclerosis Progression

Role of Platelets in the Development of Atherosclerosis.

Platelet-vessel wall interactions in atherosclerotic disease

Platelets in Inflammation and Atherogenesis

Platelets mediate oxidized low-density lipoprotein-induced monocyte extravasation and foam cell formation

Platelet Implication in Atherosclerosis Pathogenesis

Platelets: key players in vascular inflammation

Platelet Interaction with Innate Immune Cells

Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis

Targeting Platelet in Atherosclerosis Plaque Formation: Current Knowledge and Future Perspectives

The Role of Platelets in Atherosclerosis: A Historical Review

Atherosclerosis: cell biology and lipoproteins--new mechanistic links in atherosclerosis: chemokines mediating the effects of lipids, platelets and dendritic cells.

Platelets as an inter‐player between hyperlipidaemia and atherosclerosis

Platelets as therapeutic targets to prevent atherosclerosis

The role of platelets in the recruitment of leukocytes during vascular disease

Mechanisms of platelets induced atherosclerosis:research progress

Platelets in Thrombosis and Atherosclerosis: A Double-Edged Sword

Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19

Platelets and vascular integrity: how platelets prevent bleeding in inflammation.